Bioactivity | KSL 128114, a peptide inhibitor of syntenin, binds the PDZ1 domain of syntenin with nanomolar affinity. KSL 128114 is resistant toward degradation in human plasma and mouse hepatic microsomes and displays a global PDZ domain selectivity for syntenin[1]. |
Invitro | KSL-128114 (~20 μM) 对原发性GBM细胞活力具有抑制作用,并在患者来源的异种移植小鼠模型中显著延长了生存时间。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> KSL 128114 相关抗体: |
CAS | 2757292-12-7 |
Sequence | Ac-{d-Arg}-Arg-{d-Arg}-Gly-{d-Arg}-Lys-{d-Lys}-Arg-{d-Arg}-Ser-His-Trp-Tle-Chg-Asp-Ile |
Shortening | Ac-{d-Arg}-R-{d-Arg}-G-{d-Arg}-K-{d-Lys}-R-{d-Arg}-SHW-{Tle-Chg}-DI |
Formula | C96H165N39O21 |
Molar Mass | 2201.59 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Linda M Haugaard-Kedström, et al. A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma. J Med Chem. 2021 Feb 11;64(3):1423-1434. |
KSL 128114
AD